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ABSTRACT 
Objective: Zika virus infection is fast becoming a major public health concern in both developed and developing countries of the world because of 
its association with microcephaly and Guillain Barre Syndrome. Assessment of its knowledge and understanding among different healthcare 
practitioners are essential for prevention and control especially in developing countries such as Nigeria. Our aim was to assess the knowledge of the 
virus and its associated factors among healthcare professionals (HCPs). 
Methods: A cross-sectional study was conducted from June 10 to August 28, 2016, among health care professionals who were selected by non-
probability convenience sampling technique. The respondents were selected from various practice settings including academic institution, private and 
government hospitals in Enugu State, Nigeria. A validated and pilot tested 15 item questionnaire was used to evaluate respondents’ knowledge of ZIKV 
infection. Descriptive statistics and chi-square were used to analyze respondents’ level of knowledge and its associated factors using SPSS version 16. 
Results: Two hundred (200) respondents participated in this study with more than half (53.0%) being male, and most were either Physician or 
Pharmacist (59.5%). Our results also showed that most of the respondents (128, 64.0%) had poor knowledge of ZIKV infection. However, among the 
respondents assessed, the Pharmacists and the Physicians had better knowledge of the disease as the test statistics were statistically significant at 
X2=16.722, p=0.033. HCPs in the academia had better knowledge compared to those that are self-employed or practicing in private or government 
hospitals (X2=17.178, p=0.028). 
Conclusion: Our findings suggest that most of the HCPs assessed in this study had poor knowledge of ZIKV infection. However, professional status, 
place of service, and study site were found to be associated with the respondents’ level of knowledge. Hence, through sensitization and awareness 
campaigns through the media, seminars, and workshops aimed at educating HCPs on the disease should be encouraged.  
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Zika virus (ZIKV) infection has become a disease of global 
importance with its sporadic outbreaks from one region to another. 
ZIKV was originally identified in rhesus monkeys in the Zika forest 
of Uganda in 1947 [1]. Since ZIKV infection was reported in Uganda, 
there has been documented evidence of its occurrence in other 
African, Asian, and South American countries such as Nigeria, 
Senegal [2], Ivory Coast, Egypt, India, Malaysia, Philippine [3], 
Indonesia [4, 5] Colombia, and Brazil [6]. In all, as of May 2016, ZIKV 
infection has been reported in 58 countries and territories around 
the world, especially in the South Americas [7]. 
ZIKV is a Flavivirus transmitted by the bite of Aedes species of 
mosquitoes, especially Aedes aegypti [8, 9]. The transmission of ZIKV 
can also occur through sexual intercourse, as sexual transmission have 
been reported in Argentina, France, Chile, Italy, and New Zealand [10, 
11]. Furthermore, ZIKV can equally spread by vertical transmission via 
mother-to-child transmission during pregnancy [12–14]. However, 
although ZIKV infection can be largely asymptomatic, its clinical 
presentations may include a headache, mild fever, arthralgia, 
conjunctivitis, myalgia, and cutaneous maculopapular rash [15].  
ZIKV infection has been associated with microcephaly and Guillain-
Barre syndrome (GBS) in the newborn [16, 17]. Microcephaly is a 
disorder in which a newborn child has an abnormally developed head 
size much smaller in relation to babies of same sex and age. Head size 
is often used as an important parameter for monitoring brain growth 
in children. The clinical manifestations of microcephaly may vary from 
mild to severe and include intellectual disability, poor speech, seizures, 
swallowing problems, hearing, and sight abnormalities [18, 19]. 
However, its treatment is only symptomatic and supportive as there is 
no proven cure at present. On the other hand, GBS is a severe 
autoimmune disorder in which the body’s immune system attack and 
destroy healthy nerve cells in the peripheral nervous system. Its 
clinical presentations include muscle weakness, numbness and 
tingling of body extremities, loss of bladder control, labored breathing, 
back pain, and ultimately paralysis [20, 21]. 
The first case of ZIKV infection was reported in Nigeria in a study 
conducted in 1968. The dreaded infection was also documented in 
some patients in the country between the period spanning 1971 to 
1975. Nigeria is a developing country in West Africa with an 
estimated population of over 182 million people [22]. Nigeria is a 
high-risk country for ZIKV infection due to limited resources, 
overpopulation, and slow response by the government during times 
of disease outbreak. As the custodian of health, HCPs need to be well 
informed of the disease. In Nigeria, there is little or no study on the 
knowledge of HCPs regarding Zika virus infection especially 
pertaining to strategies for its prevention, clinical presentations, 
diagnosis, and possible treatment. Knowledge of ZIKV infection will 
enable HCPs to better handle the problem should the need arise. 
Therefore, this study aimed to assess the knowledge of ZIKV 
infection and its associated factors among Physicians, Pharmacists, 
Nurses, and Medical laboratory scientists practicing in some selected 
health care facilities and institution in Enugu state, Nigeria. 
MATERIALS AND METHODS 
Study design 
A cross-sectional study was conducted to assess the knowledge of 
Zika virus infection among health care professionals in Enugu State, 
from June 10 to August 28, 2016. 
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The study was conducted in some selected health care facilities and 
a higher institution, both private and government-owned 
establishments. The facilities and institution used were the 
University of Nigeria Teaching Hospital (UNTH), Enugu State 
University Teaching Hospital (ESUTH), Bishop Shanahan Hospital 
(BSH), University of Nigeria Medical Center, University of Nigeria, 
Nsukka as well as some self-employed HCPs in Enugu State, Nigeria. 
Study population 
Two hundred respondents were randomly selected from the various 
study sites. The respondents included in the study were Physicians, 
Pharmacists, Nurses and Laboratory scientists who gave informed 
consent to participate in the study. 
Study instrument 
The instrument used for the study was developed by a team of 
experts on infectious disease management. The questionnaire items 
were obtained after careful and extensive literature search. The 
questions were based on the history, characteristics, 
symptomatology, transmission, diagnosis, complications, and 
treatment of Zika virus infection. Its face and content validity were 
assessed by experts in infectious disease management of the 
University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu State. 
Thereafter, irrelevant questions were removed while important but 
omitted items were added as required. A pilot study was conducted 
using 20 respondents from Enugu State University Teaching 
Hospital, Enugu State, who were not included in the actual study. 
Few adjustments were made were necessary after the pilot study as 
it was aimed at ensuring that the questions were clear, 
unambiguous, and comprehensive. The final questionnaire was 
divided into section A and section B. Section A contains respondents’ 
demographic data such as gender, age, years of experience, 
professional status, and place of service, while section B contains 15 
items assessing respondents’ knowledge of ZIKV infection. 
Data collection 
The self-administered questionnaires for the study were distributed 
to the respondents at their place of work with the aid of trained 
research assistants. Strict measures were observed to ensure that 
none of the respondents was assisted in completing the 
questionnaire. The questionnaires were completed and returned 
almost immediately without delays. 
Ethical considerations 
Ethical approval was granted for this study by the Health Research 
Ethics Committee of the University of Nigeria Teaching Hospital, 
Ituku-Ozalla, Enugu State, Nigeria. The permission approval 
number is NHREC/05/01/2008B-FWA00002458-1RB00002323. 
Both oral and written consent was sought from the prospective 
participants. Only respondents who agreed to participate in the 
research were considered for selection. Strict confidentiality of 
respondents’ information was maintained during and after data 
collection. 
Data analysis 
The respondents’ demographic characteristics and level of 
knowledge were analyzed as frequencies and percentages. Chi-
square was used to determine the association between demographic 
characteristics and level of knowledge. All statistical analysis was 
performed using SPSS version 16. 
RESULTS 
Out of the 248 questionnaires administered, 200 were returned 
giving a response rate of 80.6%. 
Table 1 showed that more than half (53.0%) were male, and the 
majority were either Physicians or Pharmacists (59.5%). As regard 
respondents’ place of service, most of the healthcare professionals 
assessed were practising in government establishments (62.0%), 
while majority work in a tertiary hospital (UNTH). 
 
Table 1: The demographic characteristics of the study population 
Characteristics Frequency Percentage 
Gender   
 Male 106 53.0 
 Female  94 47.0 
Age (Years)   
 21-30 37 18.5 
 31-40 62 31.0 
 41-50 59 29.5 
 51-60 36 18.0 
>60 6 3.0 
Professional status    
 Physician 58 29.0 
 Pharmacist 61 30.5 
 Nurse 55 27.5 
 Laboratory Scientist 24 12.0 
Years of experience   
 0-5 61 30.5 
 6-10 43 21.5 
 11-15 41 20.5 
>15 54 27.0 
Place of service   
 Private Hospital 38 19.0 
 Government 124 62.0 
 Academics 6 3.0 
 Self-employed 28 14.0 
 Retired 4 2.0 
Study site   
 UNTH 58 29.0 
 UNN 6 3.0 
 UN Medical Center 44 22.0 
 BSH 37 18.5 
 ESUTH 20 10.0 
 Self-employed 35 17.5 
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Knowledge of zika virus infection 
It’s true that greater percentage of the HCPs (75%) knew that Zika 
infection is chiefly transmitted through mosquito bites, only a few 
(13%) of them knew the symptoms of the disease. About 97.5% of 
the respondents could not give an example of an area with Zika 
outbreak. However, most of them knew that a pregnant woman with 
Zika infection can pass that to her unborn child causing serious birth 
defects. The questions and their responses for assessing knowledge 
of Zika Virus infection among HCPs are shown in table 2. 
 
Table 2: Knowledge of zika virus infection among healthcare professionals 
Questions Positive frequency (%) Negative frequency (%) 
What type of virus is Zika? 46(23) 152(76) 
Do you know where Zika Virus came from? 64(32) 136(68) 
The chief mode of transmission of Zika is through mosquito bites 150(75) 50(25) 
 Maternal/fetal, blood transfusion and sexual transmissions are  
other modes of transmissions of zika infection 
120(60) 80(40) 
Do you know the symptoms of Zika infection? 26(13) 174(87) 
Zika, dengue and chikungunya diseases have similar symptoms 86(53) 114(57) 
People with Zika virus infection require hospitalization?  128(64) 71(35.5) 
Zika virus can be treated with antiviral agents 82(41) 118(59) 
 A blood or urine test cannot confirm a Zika infection.  48(24) 152(76) 
 Zika virus can be prevented by vaccination 78(39) 120(60) 
 Protective coverings may not be necessary for zika prevention 50(25) 150(75) 
Zika virus infection in pregnant women causes birth defects 132(66) 68(34) 
I know an area with zika outbreak 3(1.5) 195(97.5) 
Pregnant women and/or those trying to get pregnant should not travel to 
places with zika outbreaks.  
139(69.5) 61(30.5) 
 A pregnant woman can pass zika virus to her fetus 146(73) 54(27) 
 
 
Fig. 1: Level of knowledge of ZIKV infection 
 
Fig. 1 showed that most of the HCPs (128, 64.0%) had poor 
knowledge of ZIKV infection. However, among the respondents 
assessed, the Pharmacists and the Physicians had better 
knowledge of the disease as the test statistics were statistically 
significant at X2=16.722, p=0.033. HCPs in the academia had 
better knowledge compared to those that are self-employed or 
practising in private or government hospitals (X2=17.178, 
p=0.028) (table 3). 
 
Table 3: The relationship between demographic factors and level of knowledge of Zika virus infection among healthcare professionals 
Characteristics Level of knowledge X2 p-value 
Poor (n=128) Fair (n=64) Excellent (n=8) 
Gender      
 Male 72(67.92) 29(27.36) 5(4.71) 1.849 0.397 
 Female  56(59.57) 35(37.23) 3(3.19)   
Age (years)      
 21-30 24(64.86) 12(32.43) 1(2.70) 5.460 0.707 
 31-40 36(58.06) 21(33.87) 5(8.06)   
 41-50 38(64.40) 19(32.20) 2(3.39)   
 51-60 26(72.22) 10(27.77) 0(0.00)   
>60 4(66.67) 2(33.33) 0(0.00)   
Professional status       
 Physician 34(58.62) 21(36.21) 3(5.17) 16.722 0.033* 
 Pharmacist 36(59.02) 21(34.43) 4(6.56)   
 Nurse 45(81.82) 9(16.36) 1(1.82)   
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 Laboratory Scientist 11(45.83) 13(54.17) 0(0.00)   
Years of experience      
 0-5 38(62.30) 19(31.15) 4(6.56) 6.133 0.408 
 6-10 25(58.14) 17(39.53) 1(2.33)   
 11-15 27(65.85) 11(26.83) 3(7.32)   
>15 37(68.52) 17(31.48) 0(0.00)   
Place of service      
 Private Hospital 32(84.21) 6(15.79) 0(0.00) 17.178 0.028* 
 Government 74(59.68) 43(34.68) 7(5.65)   
 Academics 1(16.67) 4(66.67) 1(16.67)   
 Self-employed 19(67.86) 9(32.14) 0(0.00)   
 Retired 2(50.00) 2(50.00) 0(0.00)   
Study site      
 UNTH 36(62.07) 20(34.48) 2(3.44) 26.920 0.003* 
 UNN 1(16.67) 4(66.67) 1(16.67)   
 UN Medical Center 28(63.640 11(25.00) 5(11.36)   
 BSH 31(83.78) 6(16.22) 0(0.00)   
 ESUTH 9(45.00) 11(55.00) 0(0.00)   
 Self-employed 23(65.71) 12(34.29) 0(0.00)   
*significant at p<0.05 
 
DISCUSSION 
Assessment of knowledge of infections and procedures among HCPs 
have being studied and documented [23]. This study aimed to assess 
the knowledge of ZIKV infection and its associated factors among 
health care professionals in some selected health care facilities and 
institution in Enugu State, Nigeria. Our findings showed that most of 
the respondents had poor knowledge of ZIKV infection. Sixty-four 
percent (64.0%) of the 200 respondents assessed had poor 
knowledge of ZIKV infection. However, professional status, place of 
service and study site was associated with the level of knowledge 
among the respondents, as the physicians, pharmacists and HCPs in 
the academia had better knowledge of the infection. 
In the present study, overall knowledge of ZIKV infection among 
Physicians, Pharmacists, Nurses and Medical laboratory scientists 
assessed was poor. This finding is similar with the reports of 
previous studies even though they assessed only the Physicians or 
Dental practitioners [24, 25]. Unhealthy information seeking 
behaviour or neglect among health workers may explain their poor 
knowledge of ZIKV infection as found this study. Other possible 
explanation could be the ineffective dissemination of information by 
the media especially during the recent outbreak of ZIKV in Brazil 
prior to the Olympic Games.  
Regarding factors associated with level of knowledge, professional 
status, place of service, and study site were found to be associated 
with respondents’ knowledge of ZIKV infection. Our result showed 
that respondents who were Pharmacists or physicians had better 
knowledge than the Nurses and Medical Laboratory Scientists. This 
disparity in knowledge could be attributed to better opportunities, 
access and utilization of medical journals and newsletters, 
workshop/conference attendance and participation by the former. 
Additionally, we found that HCPs who are in academia or those that 
practice in government-owned health facilities had better 
knowledge compared to those that are self-employed or work in 
private hospitals and clinics. Surprisingly, a contrary finding was 
reported in a study conducted in Indonesia, where the authors 
observed that Physicians in private hospitals had a higher odd of 
having good knowledge of ZIKV infection compared to those that 
work in government hospitals [24]. Since most people in Nigeria 
prefer accessing medical care in government hospitals because it’s 
less expensive and most often have qualified and competent HCPs 
compared to the private hospital. Hence, HCPs in the government 
hospital often have firsthand up-to-date information on prevailing 
disease conditions within and outside the country. Other possible 
explanation could be because the government routinely sponsors 
their staff for update seminars, workshop and conferences, which 
may not be obtainable in most private hospitals.  
Furthermore, as expected, HCPs in an academic institution or its 
environment (University of Nigeria, Nsukka and its Medical Center) 
were found to have better knowledge of ZIKV infection than those in 
tertiary, secondary, and private hospitals. Our finding could be 
because HCPs in the academia or its environment are usually alert to 
research opportunities, thus are current with recent developments 
on health issues worldwide. 
The HCPs in this study knew that mosquito bite is the chief mode of 
transmission of ZIKV infection. It is surprising therefore that two 
third of them did not agree that protective coverings are important 
preventive measures to take against the infection. Similarly, 60% of 
the respondents wrongly chose vaccination as a preventive measure. 
These findings suggest that the assessed HCPs have poor knowledge 
of the preventive practices towards contacting ZIKV infection. 
Literature has shown that avoidance of travel to areas with active 
ZIKV transmission is one of the best methods of preventing ZIKV 
infection. Another method is avoiding mosquito bites especially in 
areas endemic to ZIKV infection. They had good knowledge of the 
fact that ZIKV infection during pregnancy could cause serious birth 
defects. Close to 70% knew that pregnant women and/or those 
trying to get pregnant should not travel to places with outbreaks. 
However, only very few knew these places with Zika outbreaks. It is 
of great concern to note that almost all the HCPs in this study could 
not recognize the signs and symptoms of ZIKV infection. The 
majority did not know that Zika, Dengue and Chikunguya diseases 
have similar symptoms [26]. These findings may imply that even the 
physicians among them may not be able to make a differential 
diagnosis of ZIKV infection. However, because of the broadness of 
the differential diagnosis of ZIKV, the Centers for Disease Control 
and Prevention(CDC) advice that patients with suspected ZIKV 
infection should also be evaluated and managed for possible dengue 
and chikunguya infections. The majority knew that ZIKV infection 
may not be so serious as to require hospitalization. Greater 
percentage thought that the infection can be treated with antiviral 
agents. It is documented that ZIKV infection has no specific 
treatment options [27]. The symptoms are usually mild and self-
limited. HCPs need this information and knowledge to be able to 
practice effectively. There is an urgent need to advice risk patients to 
practice safe sex or to abstain from sexual intercourse especially 
during pregnancy. Physicians need to be educated on the 
importance of ophthalmic assessments in congenital ZIKV infection. 
The general public especially the HCPs need to know the importance 
of protecting people with these diseases (zika, dengue and 
chikunguya) from further mosquito exposure within the first few 
days of sickness so as to prevent other mosquitoes from becoming 
infected thereby reducing the risk of local transmission. 
LIMITATIONS 
Our study had few limitations that deserve consideration as it will 
help in better understanding and interpretation of the implication of 
its findings. The sample size used was small and disproportionate, 
hence may not be a true representative of the target population even 
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though the respondents assessed had wider coverage of different 
practice settings. Additionally, our study adopted a cross-sectional 
design, hence may have the problem of recall bias among 
respondents as the data was collected at one point in time. Despite 
this, our assessment has demonstrated that there is an obvious gap 
in knowledge which can be worked upon to improve local as well as 
global readiness to combat ZIKV infection. 
CONCLUSION 
Our findings suggest that most of the HCPs assessed in this study 
had poor knowledge of Zika virus infection and that the factors 
associated with the level of knowledge include professional status, 
place of service and/or study site. Therefore, awareness programs 
and seminars geared toward educating HCPs should be supported 
through the collective effort of well-meaning individuals, non-
governmental organizations, and the government. The media houses 
also have a significant role to play in sensitization of the entire 
populace especially during a disease outbreak. 
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